Evidence map›Paper›PMID 39202777›Full record

ArticleLife (Basel, Switzerland)2024

Impacts of Interleukin-10 Promoter Genotypes on Prostate Cancer.

Yu-Ting Chin, Chung-Lin Tsai, Hung-Huan Ma, Da-Chuan Cheng, Chia-Wen Tsai, Yun-Chi Wang, Hou-Yu Shih, Shu-Yu Chang, Jian Gu, Wen-Shin Chang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yu-Ting ChinGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Chung-Lin TsaiDivision of Cardiac and Vascular Surgery, Cardiovascular Center, Taichung Veterans General Hospital, Taichung 407219, Taiwan.
Hung-Huan MaDivision of Nephrology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung 427003, Taiwan.
Da-Chuan ChengDepartment of Biomedical Imaging and Radiological Science, China Medical University, Taichung 404333, Taiwan.ORCID 0000-0001-7955-9234
Chia-Wen TsaiGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Yun-Chi WangGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Hou-Yu ShihGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Shu-Yu ChangGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Jian GuDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-3499-0973
Wen-Shin ChangGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.
Da-Tian BauGraduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan.ORCID 0000-0002-5504-8656

Funding

Taichung Tzu Chi Hospital TTCRD113-17Taichung Veterans General Hospital TCVGH-1134801B
6 · The paper itself

Abstract

Prostate cancer (PCa) is a multifactorial disease influenced by genetic, environmental, and immunological factors. Genetic polymorphisms in the

Indexed as

genotypeinterleukin-10prostate cancerSNP

Identifiers

PMID39202777
PMCPMC11355935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.